1. Considerations for Good Pharmacovigilance Outsourcing Practices

   • Giovanni Furlan
   • Bert van Leeuwen
   • Brian Edwards

   Current Opinion 13 March 2017 Pages: 75 - 80

2. Defining Biological Subsets in Systemic Lupus Erythematosus: Progress Toward Personalized Therapy

   • Nailú Angélica Sinicato
   • Mariana Postal
   • Timothy B. Niewold

   Leading Article 25 January 2017 Pages: 81 - 88

3. An Evaluation of the Effectiveness of Risk Minimization Measures for Tigecycline in the European Union

   • Vera Frajzyngier
   • Alvaro Quintana
   • Scott Rottinghaus

   Original Research Article 22 February 2017 Pages: 89 - 99

4. Additional Risk Minimisation Measures for Medicinal Products in the European Union: A Review of the Implementation and Effectiveness of Measures in the United Kingdom by One Marketing Authorisation Holder

   • Elaine Agyemang
   • Lorna Bailey
   • John Talbot

   Original Research Article Open access 29 March 2017 Pages: 101 - 112

   

5. Quantitative Methods for Safety Monitoring of Rare Serious Adverse Events

   • Susan P. Duke
   • Christi Kleoudis
   • Eric Lewis

   Original Research Article 25 January 2017 Pages: 113 - 118

   

6. Correlation Between Elimination Parameters of Phenytoin and Carbamazepine in Patients with Epilepsy Receiving Both Drugs Concomitantly: A Preliminary Study

   • Duangchit Panomvana
   • Janthima Methaneethorn
   • Thaveechai Vachirayonstien

   Original Research Article 17 March 2017 Pages: 119 - 124

   

7. Forum

   Update 03 March 2017 Pages: 125 - 138

8. Major Pharmaceutical Conferences and Courses

   Update 20 February 2017 Pages: 139 - 141